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        The risk of asthma from severe paramyxoviral 
infection in both human and experimental 
models is well documented (  1  –  3  ). This virally 
imparted risk presents an interesting paradox; 
although the primary antiviral response is dom-
inated by production of IFN     /      and IL-12, 
which are hallmarks of a Th1 response, rhinor-
rhea and mucous cell metaplasia also develop. 
These conditions are driven by IL-13, which is 
a hallmark Th2 cytokine (  4, 5  ). The produc-
tion of antiviral IgE, along with neutralizing 
IgG antibodies, provides a further link between 
these disparate responses (  6  –  10  ). In fact, IgE se-
rum concentrations have been correlated with 
subsequent wheezing in infants with respiratory 
viral infection and with the risk of otitis media 
with eff  usion in children (  10, 11  ). How a Th1-
biased response generates a Th2 phenotype is 
not known, although we now show that the 
high-affi   nity receptor for IgE on DCs bridges 
the antiviral Th1 response to the atopic/pro-
asthmatic Th2 response. 
  The role of the high-affi   nity receptor for 
IgE (Fc    RI) on human conventional DCs (cDCs) 
has been assumed to be antigen focusing, with 
expression being tightly regulated by serum 
IgE levels, much like it is on basophils (  12, 13  ). 
Fc     RI has not been reported on mouse DCs, 
and little is known of what role it might play 
during an antiviral response. Indeed, the role 
of the cDCs in an antiviral immune response is 
not fully understood. Initial lung cDC migration 
to draining lymph nodes, and subsequent anti-
gen presentation, has been examined (  14  –  16  ). 
However, the role of those cDCs that remain 
in or are attracted to the lung parenchyma dur-
ing a primary response has not been evaluated. 
Although, in the case of secondary viral infec-
tions or challenge responses to OVA, the evi-
dence suggests that these cells are involved in 
recruitment of memory eff  ector T cells ( 17, 18 ). 
We have developed a mouse model of viral 
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  Respiratory viral infections are associated with an increased risk of asthma, but how acute 
Th1 antiviral immune responses lead to chronic infl  ammatory Th2 disease remains unde-
fi  ned. We defi  ne a novel pathway that links transient viral infection to chronic lung disease 
with dendritic cell (DC) expression of the high-affi  nity IgE receptor (Fc    RI    ). In a mouse 
model of virus-induced chronic lung disease, in which Sendai virus triggered a switch to 
persistent mucous cell metaplasia and airway hyperreactivity after clearance of replicating 
virus, we found that   FceRIa      /        mice no longer developed mucous cell metaplasia. Viral 
infection induced IgE-independent, type I IFN receptor  –  dependent expression of Fc    RI     on 
mouse lung DCs. Cross-linking DC Fc    RI     resulted in the production of the T cell chemoat-
tractant CCL28.   FceRIa      /        mice had decreased   CCL28   and recruitment of IL-13  –  producing 
CD4     T cells to the lung after viral infection. Transfer of wild-type DCs to   FceRIa      /        mice 
restored these events, whereas blockade of CCL28 inhibited mucous cell metaplasia. There-
fore, lung DC expression of Fc    RI     is part of the antiviral response that recruits CD4     T 
cells and drives mucous cell metaplasia, thus linking antiviral responses to allergic/asth-
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of the high-affi   nity receptor for IgE (Fc     RI     ), and this ex-
pression remained detectable for 2  –  3 wk after SeV inoculation 
(  Fig. 2, A and B  ).   This response was specifi  c to lung cDCs be-
cause there was no detectable expression of Fc     RI      on cDCs 
isolated from draining lymph nodes or spleen during SeV in-
fection (unpublished data). CD23, the low-affi   nity receptor 
for IgE, was not induced during the infection (  Fig. 2 B  ). Us-
ing intranasal administration of the intravital dye CFSE, which 
labeled lung cells present at the time of its administration but 
not cells that subsequently migrated into the lung, we were 
able to show that Fc     RI     -expressing cDCs were present in 
the lung at the time of the initial viral inoculation and had not 
migrated into the lung after the onset of infection (  Fig. 2, 
C and D  ). The level of expression of Fc     RI      on lung cDCs 
at PI day 7 was similar to levels seen on c-kit      lung mast cells 
(  Fig. 2, A and E  ). Increased expression of Fc     RI after viral in-
fection was relatively selective for cDCs and mast cells because 
we did not detect expression of Fc     RI      on lung CD4      or 
CD8      T cells, B220      B cells, Mac-3      macrophages, or Gr-1      
neutrophils (unpublished data). Expression of Fc     RI      was de-
tected on 20  –  40% of lung pDCs at PI day 3 (unpublished data), 
bronchiolitis that reproduces disease traits associated with 
asthma (  2  ). In this model, Fc     RI was expressed on lung cDCs 
only during the antiviral response, and these cells were criti-
cal for the development of postviral mucous cell metaplasia. 
Indeed, mice defi  cient in Fc     RI (  FceRIa    –  /  –     ) failed to recruit 
IL-13  –  producing CD4      T cells to their lungs after viral infec-
tion. Cross-linking the      -chain of Fc     RI (Fc     RI     ) on lung 
cDCs produced a CD4      T cell chemoattractant, CCL28, and 
blockade of this chemokine prevented development of post-
viral mucous cell metaplasia. Thus, these studies provide a 
novel insight into how the antiviral response leads to a potent 
Th2 response through Fc     RI      on lung cDCs. 
    RESULTS   
    FceRIa    –  /  –      mice fail to develop airway mucous cell metaplasia 
  We infected   FceRIa    –  /  –      mice or WT littermates with the 
mouse paramyxovirus Sendai virus (SeV). Each strain ex-
hibited similar morbidity (as monitored by weight loss), 
development of an adaptive immune response (as indicated 
by the development of SeV-specific CD8      T cells), and 
clearance of virus from the lung (based on SeV copy number) 
during the acute phase of viral infection (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20070360/DC1). 
Previous work in this model has shown that replicating 
virus is fully cleared by postinoculation (PI) day 12, with the 
subsequent development of long-lasting mucous cell meta-
plasia evident by PI day 21 (  2  ). Despite a similar acute re-
sponse to viral infection, we found a marked decrease in 
the number of Muc5ac-expressing mucous (goblet) cells in 
the airways of   FceRIa    –  /  –      mice compared with WT mice at 
PI day 21 (  Fig. 1  ).   We have previously shown that Muc5ac 
induction by PI day 21 depends on production of IL-13 (  5  ). 
Therefore, these fi  ndings suggested a link between Fc     RI      
expression and IL-13 production in the airway response to 
viral infection. 
  Paramyxoviral infection induces high-level expression 
of Fc    RI     on resident lung DCs 
  We next identifi  ed which cell type in the lung might express 
Fc     RI      in the setting of viral infection. In rodents, the high-
affi   nity IgE receptor has been identifi  ed only on mast cells, 
basophils, and possibly eosinophils (  19  ). However, in hu-
mans, this receptor is also found on skin and peripheral blood 
cDCs, as well as plasmacytoid DCs (pDCs), albeit as a trimeric 
form (Fc     RI               ) that lacks the Fc     RI      chain (  13, 20, 21  ). 
Therefore, we questioned whether this form of the receptor 
might also be found on lung parenchymal cDCs after viral 
infection. Using forward/side scatter characteristics and a 
high level of CD11c expression to identify lung cDCs, we 
have observed that SeV infection leads to a rapid and sus-
tained decrease in the number of lung cDCs, but the cDC 
population remaining in the lung becomes more mature and 
diff  erentiated (  22  ). Therefore, we examined this population 
of resident cDCs in more detail. 
  Before infection, lung cDCs failed to express Fc     RI; how-
ever, by PI day 3, this population began to express the       chain 
  Figure 1.     Inhibition of chronic mucous cell metaplasia after viral 
infection in       FceRIa      /                mice. (A)   FceRIa       /       and WT littermate control 
mice were inoculated with SeV, and lung sections were immunostained 
for Muc5ac at PI day 0 and 21. Representative images from PI day 21 are 
shown. Bar, 40      m. (B) Quantifi  cation of mucous cells based on immuno-
staining conditions from A. (C) Lungs from A were subjected to real-time 
PCR for   Muc5ac   mRNA. For B and C, values represent the mean       the 
SEM for three to fi  ve mice. *, P       0.05 versus WT PI day 21.     JEM VOL. 204, October 29, 2007 
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Fc     RI proteins, real-time PCR assays showed that lung cDCs 
expressed   Fc    RI      , but not   Fc    RI       mRNA after viral infec-
tion, whereas MC9 mast cells contained high levels of both 
  Fc    RI       and   Fc    RI       mRNA (Fig. S2 C). Thus, mouse lung 
cDCs express the trimeric (Fc     RI               ) form of the Fc     RI 
receptor. This is the same form of Fc     RI that is expressed by 
human DCs, but expression on mouse cDCs requires induc-
tion by a productive viral infection. This requirement may 
explain the failure to detect Fc     RI expression on mouse DCs 
in previous works. 
  Type I IFN receptor, but not IgE, regulates DC expression 
of Fc    RI     
  Next, we explored what component of the antiviral response 
is responsible for induction of Fc     RI      expression on lung 
cDCs during a paramyxoviral infection. Serum IgE level 
tightly regulates expression of the high-affi   nity IgE receptor in 
humans, so we reasoned that total IgE and, more likely, SeV-
specifi  c IgE might drive Fc     RI receptor expression after viral 
infection in mice. However, we found that serum total IgE 
and SeV-specifi  c IgE do not increase until PI day 7 (  Fig. 3 A  ).   
This time course lags behind the onset of expression of Fc    RI      
which is consistent with reports of Fc     RI                on human 
pDCs (  21  ). This pDC population was distinct from the lung 
cDC population because Fc     RI     -expressing lung cDCs did 
not express the pDC/B cell marker B220 (Fig. S2 A, available 
at http://www.jem.org/cgi/content/full/jem.20070360/DC1). 
Expression of Fc     RI did not infl  uence cDC maturation or 
diff  erentiation during viral infection. We found no diff  erence 
in the levels of expression of MHC class II, CD11b, CD80, or 
CD86 between lung cDCs from   FceRIa    –  /  –      versus WT mice 
(Fig. S2, A and B). Similarly, we found no infl  uence of Fc     RI 
on the expression of CD23. 
  Based on work with isolated cells, mice have been reported 
to be obligate expressers of the tetrameric form (Fc     RI                    ) 
of Fc     RI (  23  ). To determine if mouse lung cDCs were, 
indeed, expressing the tetrameric and not trimeric form of 
the receptor, we analyzed mouse lung cDCs for expression 
of each Fc     RI component chain. Immunoprecipitation of 
Fc     RI with an anti-Fc     RI      antibody, and subsequent Western 
blot with anti-Fc     RI      or -Fc     RI      antibodies, showed that 
lung cDCs isolated after SeV infection expressed Fc     RI     , 
but not Fc     RI      (  Fig. 2 F  ). In contrast, MC9 mast cells expressed 
both Fc     RI      and Fc     RI     . In concert with these fi  ndings for 
  Figure 2.     Up-regulation of Fc     RI      expression on lung DCs after viral infection. (A) WT mice were inoculated with SeV, and CD11c      lung cDCs or 
c-kit      mast cells (MC) were analyzed by fl  ow cytometry using anti-Fc    RI     mAb and isotype control mAb at PI day 0 and 7. (B) Conditions in A were used 
for fl  ow cytometry for Fc    RI     and CD23 on the indicated PI day. Values represent the mean       the SEM for   n        6 mice. *, P       0.05 versus PI day 0. (C) WT 
mice were given PBS ([  –  ] CFSE) or CFSE ([+] CFSE) intranasally and inoculated with SeV. Lung cDCs were isolated at PI day 7, and expression of CFSE 
and Fc    RI     was determined by fl  ow cytometry. (D) Quantifi  cation of data from C. Values represent the mean       the SEM for   n        3 mice. (E) Lung cDCs 
(CD11c     ) and mast cells (c-kit     ) were analyzed by fl  ow cytometry for Fc    R1    , as in A. Values represent the mean       the SEM for fold mean fl  uorescence 
intensity Fc    RI     signal versus isotype control mAb for three mice per time point. (F) Cell lysates from lung cDCs (PI day 5) or MC/9 mast cells were sub-
jected to immunoprecipitation with anti-Fc    RI     mAb. Immunoprecipitated complexes (IP) were then Western blotted with anti-Fc    RI     or  -Fc   RI     mAb. 
Representative blots are shown for two separate experiments.     2762 Fc    RI     AND VIRUS-INDUCED MUCOUS CELL METAPLASIA | Grayson et al.
Therefore, IgE levels do not appear to regulate the appearance 
of Fc     RI      on lung cDCs after viral infection in mice. 
  Given that initial expression of Fc     RI      developed at the 
same time as IFN-dependent responses in this viral model, we 
examined whether IFN signaling was necessary for Fc     RI ex-
pression. Indeed, we found that type I IFN receptor (IFNAR)  –
  defi  cient (  IFNAR         /      ) mice no longer exhibited an increase 
in Fc     RI      expression on lung cDCs during viral infection 
(  Fig. 3, C  –  E  ). In contrast, mice that were defi  cient for   CD1d  , 
  CD4  ,   CD8  ,   perforin  , or   MyD88   gene expression showed no 
defect in Fc     RI      expression after viral infection (unpub-
lished data). Thus, although IFNAR is critical for expression 
of Fc     RI      on lung cDCs after viral infection, there is no 
substantial role for NKT cells, CD4      T cells, or CD8      T cells, 
or for the innate antiviral perforin- or MyD88-dependent Toll-
like receptor pathways in this process. 
  We next examined the mechanism for IFN-dependent 
expression of Fc     RI on DCs. We recognized that direct IFN 
treatment of human lung pDCs failed to increase Fc     RI      
expression (  21  ). This fi  nding suggested that IFN-dependent 
increases in Fc     RI expression on lung DCs may involve 
other cell types besides DCs. Accordingly, we next   determined 
whether IFNAR expression on cDCs was necessary for 
Fc     RI expression after viral infection. For these experiments, 
we purifi  ed lung cDCs from   IFNAR       /         and WT control 
mice. We verifi  ed that the cells we purifi  ed exhibited typical 
DC morphology (  Fig. 4  ).   Purifi  ed lung cDCs were loaded 
with CFSE (to discriminate from endogenous cDCs) and 
transferred into WT or   IFNAR       /         recipients. We found that 
either   IFNAR       /         or WT cDC transfer into WT mice allowed 
for expression of Fc     RI      on cDCs (Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20070360/DC1). 
In contrast, transfer of either genotype of cDCs into   IFNAR       /         
mice did not permit expression of Fc     RI      on cDCs after 
viral infection. These fi  ndings imply that IFN acts through 
another intermediate cell to activate Fc     RI expression on 
lung cDCs. 
  Lung cDCs from virus-infected mice drive IL-13 production 
from CD4     T cells 
  Because IL-13 is thought to drive postviral mucous cell meta-
plasia, and Th2 cells are thought to be a likely source of IL-13, 
we reasoned that generation of Th2 cells might be altered as 
a result of Fc     RI      engagement on cDCs (  5  ). CD8         cDCs, 
like those found in the lung, have been shown to drive T cell 
development toward a Th2 phenotype in vitro (  24  ). There-
fore, to determine if induction of IL-13  –  producing CD4      
T cells depended on engagement of Fc     RI     , we examined 
IL-13 production in an in vitro cell culture system that contains 
CD4      T cells and cDCs. OVA-specifi  c CD4      T cells (OT-II 
cells) were cultured with lung cDCs isolated from WT or 
  FceRIa       /         mice with or without SeV infection. We isolated 
cDCs at PI day 7 and verifi  ed that these cDCs had not yet 
bound IgE at this time point (unpublished data). We found 
that OT-II CD4      T cells produced IL-13 when cultured 
with antigen and cDCs, regardless of whether cDCs were 
on lung cDCs, suggesting that the level of IgE is not driving 
the expression of Fc     RI receptor under these conditions. In 
fact, we found that IgE-defi  cient (  IgE      /      ) mice continued to 
develop the same increase in Fc     RI      expression on lung 
cDCs as their WT littermates after viral inoculation (  Fig. 3 B  ). 
  Figure 3.     Effect of IgE levels and IFN signaling on up-regulation 
of Fc    RI      on lung cDCs after viral infection. (A) WT mice were 
inoculated with SeV, and serum was analyzed for total and SeV-specifi  c 
IgE levels. Values represent the mean       the SEM for three to six mice. 
(B)   IgE      /      and WT control mice were inoculated with SeV, and lung 
cDCs were analyzed by fl  ow cytometry using anti-Fc    RI     and  isotype 
control mAbs. (C)   IFNAR      /      and WT mice were inoculated with SeV, and 
lung cDCs were analyzed at PI day 5, as in B. For conditions in C, quan-
tifi  cation of fold increase in mean fl  uorescence intensity for Fc    RI    
over isotype control (D) and percentage of lung cDCs expressing Fc    RI    
(E). Values represent the mean       the SEM for four to eight mice 
per group.     JEM VOL. 204, October 29, 2007 
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  To establish that CCL28 expression was inducible in 
cDCs with a more physiological stimulus of Fc     RI activa-
tion, we loaded lung cDCs from PI day 7 with IgE against 
OVA. In this setting, we found that addition of OVA (by 
cross-linking anti-OVA IgE bound to Fc     RI      on the cDC) 
caused a marked increase in   CCL28   mRNA (  Fig. 5 C  ). Sim-
ilar results were obtained when using the anti-Fc     RI      anti-
body to directly cross-link the receptor (unpublished data). 
To determine whether Fc     RI activation also caused CCL28 
expression in vivo, we returned to experiments with the mouse 
model of virus-induced lung disease. Again, we found that 
lung levels of   CCL28   mRNA were increased after SeV infec-
tion in WT mice, and that this eff  ect was lost in   FceRIa     /         mice 
(  Fig. 5 D  ). If CCL28 was being released with engagement of 
Fc     RI, then we would expect diff  erences in the frequency of 
CD4      T cells in the lungs of   FceRIa       /         and WT mice after 
viral infection. Indeed, we found that CD4      T cells were 
signifi  cantly decreased in the lungs of   FceRIa       /         mice compared 
with WT mice at PI day 21 (  Fig. 5 E  ). 
  Because we have previously shown that mucous cell 
metaplasia after viral infection is dependent on IL-13 produc-
tion, we next examined the amount of   IL-13   and   GATA-3   
(a Th2-specifi  c transcription factor) message in lung CD4      T 
cells of WT and   FceRIa       /         mice after SeV infection (  5  ). We 
found a signifi  cant decrease in the levels of   IL-13   and   GATA-3   
mRNA in CD4      T cells from the lungs of   FceRIa       /         com-
pared with WT mice (  Fig. 5, F and G  ). These fi  ndings further 
supported the proposal that inhibition of mucous cell meta-
plasia in   FceRIa       /         mice was based on decreased accumula-
tion of IL-13  –  producing CD4      Th2 cells caused by a lack of 
production of CCL28 by the resident Fc     RI           lung cDCs. 
We also examined   IL-13   and   GATA-3   mRNA levels in the 
CD4      T cells that had or had not migrated in response to 
CCL28 in vitro. We found that there was much greater ex-
pression of both   IL-13   and   GATA-3   mRNA in T cells that 
isolated from WT or   FceRIa       /         mice or from infected or un-
infected mice (  Fig. 5 A  ).   Furthermore, cross-linking Fc     RI      
had no eff  ect on T cell production of IL-13 or proliferation 
(  Fig. 5 A   and not depicted). Thus, we conclude that lung 
cDCs are capable of driving the development of IL-13  –  pro-
ducing CD4  +   Th2 cells, but this process does not require cDC 
expression or activation of Fc     RI     . 
  Cross-linking Fc    RI     on lung DCs produces the T cell 
chemoattractant CCL28 
  Because we did not detect a requirement for cross-linking 
Fc     RI      in the development of the T cell cytokine response, 
we next assessed whether Fc     RI might be involved in the in-
duction of T cell chemoattractants. Lung cDCs were purifi  ed 
from WT mice by immunomagnetic selection at PI day 5. The 
purifi  ed cells were then cultured for 18 h with a cross-linking 
antibody against Fc     RI      or a control hamster IgG. Superna-
tants from these cultures were then used in a modifi  ed Boyden 
chamber assay to assess whether a functional T cell chemoat-
tractant had been produced. Supernatants from Fc     RI      cross-
linked cDCs induced signifi  cantly more CD4      T cell migration 
than did IgG control supernatants, indicating that engagement 
of the receptor led to production of a CD4      T cell chemoat-
tractant (  Fig. 5 B  ). To identify the chemokine receptor for this 
T cell chemoattractant, we added various chemokines (CCL5, 
CCL22, and CCL27) to the upper chamber and evaluated the 
eff  ect on chemotaxis (Fig. S4 A, available at http://www.jem
.org/cgi/content/full/jem.20070360/DC1). Only CCL27 
(C-TACK) inhibited T cell migration, indicating that the CD4      
T cells were moving in response to a CCR10 agonist. Only 
two known CCR10 agonists, CCL27 and CCL28 (MEC), 
have been identifi  ed. Using blocking mAbs, we found that the 
chemotactic activity was entirely caused by CCL28 (  Fig. 5 B  ). 
Of relevance to this work, CCL28 has been associated with 
both human asthma and mouse models of asthma (  25  –  27  ). 
  Figure 4.     Morphology of purifi  ed lung cDCs versus macrophages. Lung cDCs were isolated by positive immunomagnetic selection with macro-
phages obtained by BAL. Both cell preparations were cytocentrifuged onto slides (left two columns) and cultured in chamber slides with or without 
10      g/ml LPS for 24 h at 37  °  C (right two columns), and then imaged with modifi  ed Wright  ’  s stain and photomicrography. For each condition, representative 
photomicrographs from three separate experiments are shown. Bars, 10     m.   2764 Fc    RI     AND VIRUS-INDUCED MUCOUS CELL METAPLASIA | Grayson et al.
  Figure 5.     CCL28 production after activation of Fc     RI      on lung cDCs. (A) Lung cDCs from WT or   FceRIa     /       mice that were uninfected (PI day 0) or 
SeV-infected (PI day 7) were treated with or without anti-Fc    RI     mAb or control IgG. Cells were loaded with OVA peptide and cocultured with OVA-spe-
cifi  c CD4      T cells (OT-II) for 4 d at 37  °  C, followed by ELISA of cell supernatants for IL-13. Values represent the mean       the SEM for four to seven experi-
ments done in triplicate. (B) Lung cDCs were purified from PI day 5 and treated with an anti-Fc    RI     mAb or control IgG for 18 h at 37  °  C. Cell 
supernatants were assayed for chemotactic activity for naive CD4      T cells with and without treatment with anti-CCL28 or -CCL27 mAb. Values represent 
the mean       the SEM for three to six experiments done in triplicate. *, P       0.05 versus IgG supernatant; **, P       0.05 versus anti-CCL27 and no antibody 
treatment. (C) Lung cDCs purifi  ed at PI day 7 were loaded with anti-OVA IgE and cultured with (+) or without (  –  ) 3      g/ml OVA protein for 18 h at 37  °  C. 
Cellular RNA was subjected to real-time PCR for   Ccl28   mRNA. Values are corrected for   Gapdh   mRNA level and represent the mean       the SEM for three 
experiments. *, P       0.05 versus no OVA protein. (D)   FceRIa      /      and WT mice were inoculated with SeV, and lung levels of   Ccl28   mRNA were determined by 
real-time PCR at the indicated times. Values represent the mean       the SEM for three to fi  ve mice. (E) Lung frequencies of CD4      T cells were quantifi  ed by 
fl  ow cytometry in WT and   FceRIa      /      mice at the indicated times. Values represent the mean       the SEM for three to nine mice. (F) Lung CD4      T cells were 
purifi  ed by positive immunomagnetic selection at PI day 21 and analyzed for   Il-13   by real-time PCR. (G) Using conditions in F, expression of   GATA-3  
mRNA was analyzed by real-time PCR. (H) Percentage of total lung cells in the lymphocyte gate expressing CCR10 and CD4 by fl  ow cytometry at PI day 0 
or 10 in WT and   FceRIa     /       mice. For F  –  H, values represent the mean       the SEM for three mice. *, P       0.05 versus WT mice for D  –  H. (I) CCR10      CD4     T 
cells and CCR10         CD4     T cells were purifi  ed by fl  ow cytometry at PI day 10 and subjected to real-time PCR for   GATA-3   and   T-bet  . Values represent the 
mean       the SEM for the ratio of   GATA-3   to   T-bet   from three experiments with three mice per experiment. *, P       0.05 versus CCR10         CD4     T  cells.   JEM VOL. 204, October 29, 2007 
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    DISCUSSION   
  In this study, we show that respiratory viral infection can 
lead to expression and activation of Fc     RI on lung cDCs 
and thereby drive the development of mucous cell metaplasia 
even after the inciting infection is cleared. We examined lung 
cDCs because we previously found that the migration and 
maturation of this cell population was tightly regulated dur-
ing respiratory viral infection (  22  ). Indeed, the potent eff  ects 
of viral infection on DCs might explain why we have detected 
Fc     RI on DCs in the mouse, whereas others have not previ-
ously found this receptor on DCs (  28  ). 
  We have also shown that expression of Fc     RI in the set-
ting of a productive viral infection requires an active type I 
IFN response. In fact, expression of Fc     RI on cDCs quickly 
returns to low levels with resolution of the antiviral response, 
migrated compared with cells that did not migrate in response 
to CCL28 (Fig. S4 B). 
  Because CCL28 binds to CCR10 to recruit immune 
cells, we determined the level of CCR10      CD4      T cells in 
the lungs of WT and   FceRIa       /         mice before and after viral 
infection. We found an increase in CCR10      CD4      T cells 
in WT mice after viral infection (  Fig. 5 H  ). Furthermore, this 
increase in CCR10      CD4      T cells did not develop in  FceRIa       /         
mice. We also found that CCR10      CD4      lung T cells from 
WT mice contained increased levels of   GATA-3   mRNA 
(typically found in Th2 cells) compared with   T-bet   mRNA 
(typically found in Th1 cells;   Fig. 5 I  ). Together, these fi  nd-
ings provide further support for the proposal that activation 
of Fc     RI      on cDCs leads to preferential accumulation of 
Th2 cells in the lung after SeV infection. 
  cDC reconstitution restores CD4     T cell accumulation 
and mucous cell metaplasia after viral infection 
  To prove that Fc     RI      expression on cDCs was necessary 
for recruitment of CD4      Th2 cells to the lung and mucous 
cell metaplasia after viral infection, we performed adoptive cell 
transfer experiments with cDCs from WT or   FceRIa       /         mice 
transferred into   FceRIa       /         recipients, followed by SeV inocu-
lation. We found that reconstitution with WT cDCs restored 
postviral mucous cell metaplasia in   FceRIa       /         recipient mice 
(  Fig. 6, A and B  , and Fig. S5 A, available at http://www.jem
.org/cgi/content/full/jem.20070360/DC1).   In contrast, trans-
fer of   FceRIa       /       cDCs were unable to restore the development 
of mucous cell metaplasia after viral infection. Furthermore, 
we found that CD4      T cells isolated at PI day 21 from lungs of 
  FceRIa       /         mice that had received WT cDCs expressed   IL-13   
and   GATA-3   at signifi  cantly higher levels than mice that re-
ceived cDCs from   FceRIa       /         mice (  Fig. 6 C  ). We found no 
diff  erence in the engraftment of WT versus   FceRIa       /         cDCs, 
with both genotypes of cDCs persisting for at least 6 d after 
transfer to the recipient mice (Fig. S5 B). Together, these re-
sults indicate that Fc     RI      on lung cDCs is critical for Th2 cell 
recruitment and mucous cell metaplasia after viral infection. 
  Blockade of CCL28 inhibits postviral mucous cell metaplasia 
  We next determined the role of CCL28 in the cascade lead-
ing to mucous cell metaplasia after viral infection. For these 
experiments, we treated WT mice with an anti-CCL28  –
  blocking mAb or control IgG2b and monitored the develop-
ment of mucous cell metaplasia at PI day 21. We found a 
signifi  cant decrease in mucous cell metaplasia after treatment 
with anti-CCL28 mAb compared with control IgG (  Fig. 7, 
A and B  , and Fig. S6, available at http://www.jem.org/cgi/
content/full/jem.20070360/DC1).   We observed no signifi  -
cant diff  erence in the frequency of CD4      T cells in the lungs 
of mice treated with either anti-CCL28 mAb or control 
IgG2b (  Fig. 7 C  ). This fi  nding suggests that CCL28 is a che-
motactic factor for immune cells producing IL-13 and driv-
ing mucous cell metaplasia after viral infection, but additional 
chemoattractants also contribute to CD4      T cell accumula-
tion in the lung in this setting. 
  Figure 6.     Restoration of postviral mucous cell metaplasia in       FceRIa      /                 
mice after lung cDC transfer. (A) Lung cDCs were isolated from WT or 
  FceRIa      /      mice and transferred into   FceRIa      /      recipients 1 d before 
inoculation with SeV. At PI day 21, lung sections were obtained for immuno-
staining for Muc5ac. Representative photomicrographs are shown. Bar, 
40      m. (B) Quantifi  cation of immunostaining in A. Values represent the 
mean       the SEM for two to four recipient mice per group from two sepa-
rate experiments; *, P       0.05 versus WT DCs transferred into   FceRIa     /      
recipients. (C) For conditions in A, lung CD4      T cells were purifi  ed at PI 
day 21 and analyzed for   Il-13, GATA-3,   and   Gapdh   mRNA by real-time 
Q-PCR. Values represent the mean       the SEM from two separate experi-
ments with two to four recipient mice per experiment. *, P       0.05  versus 
  FceRI a     /       cDCs transferred into   FceRIa     /       recipients.   2766 Fc    RI     AND VIRUS-INDUCED MUCOUS CELL METAPLASIA | Grayson et al.
also uncertain. Any possible pathogenic role for IgE-depen-
dent signals remained undefi  ned, despite recognition that viral 
infections stimulate potent IgE responses along with neutral-
izing IgG antibodies (  6  –  10  ). Furthermore, increased antiviral 
IgE production is closely associated with subsequent wheez-
ing in infants after respiratory viral infection (  10  ). Moreover, 
the two major pathogens linked to asthma pathogenesis, i.e., 
respiratory syncytial virus (a paramyxovirus-like SeV) and 
rhinovirus, are both known to potently induce the produc-
tion of IgE in humans (  10, 30  –  33  ). Our fi  ndings provide 
for a novel IgE-dependent mechanism in which an antiviral 
response characterized by IFN production drives expression 
of Fc     RI on lung cDCs. IgE engagement of the receptor 
leads to release of soluble mediators that generate an atopic 
response characterized by Th2 cell activation and IL-13 pro-
duction. Consistent with this mechanism, others showed that 
passive transfer of antiviral IgE can increase the airway hyper-
reactivity caused by respiratory syncytial virus infection in 
mice, and that Fc     RI was necessary for this IgE-dependent 
response (  34  ). This eff  ect was assumed to be caused by mast 
cell activation during the viral infection. However, given the 
very low dissociation kinetics of Fc     RI-bound IgE (K  d   of 
    10       9    –  10       10   M), it is not clear that IgE during a primary vi-
ral infection would bind to mast cell Fc     RI in any signifi  cant 
quantity during the acute infection (  35  ). It is possible that the 
rapid expression of Fc     RI on lung cDCs would make these 
cells a better target cell for binding antiviral IgE because this 
cell population would have a signifi  cant number of unoccu-
pied receptors. Although we did not study this issue directly, 
it is quite possible that virus-induced airway hyperreactivity, like 
mucous cell metaplasia, is a result of engagement of Fc     RI on 
lung cDCs and not mast cells or basophils. 
  The actions of Fc     RI found on mouse lung cDCs are 
distinct from the previously described role of Fc     RI      signal-
ing on human DCs. In the human cells, Fc     RI is thought to 
help target antigens to DCs (  12  ). Because IgE production lags 
behind expression of Fc     RI, it appears that IgE may act as a 
signaling molecule for lung cDCs. Once an eff  ective adaptive 
immune response has been generated, virus-specifi  c IgE will 
be produced, bind to the cDCs, and be cross-linked by viral 
antigen. This signals cDCs to produce CCL28 and recruit 
eff  ector Th2 cells. Because Th2 recruitment to the lung is anti-
gen nonspecifi  c, it is possible that this mechanism contributes 
in other ways to allow the innate immune system to infl  uence 
the antiviral response (  36  ). For example, regulatory T cells ex-
press CCR10 and may be another important target of CCL28 
(  37  ). Thus, Fc     RI engagement on lung cDCs may provide 
mechanisms to down-regulate an ongoing Th1 response in 
the lung after viral infection. 
  These results may also bear on the increased incidence of 
asthma and allergic diseases that are being observed in more 
industrialized countries. This observation has led to the   “  hy-
giene hypothesis,  ”   in which cleaner living conditions and 
decreased childhood bacterial infections are thought to drive 
an increase in allergic disease (  38  ). Our results suggest an ad-
ditional mechanism that may explain the increased incidence 
such that expression is nearly undetectable by 21 d after viral 
inoculation. Previous work has shown that IgE levels regu-
late Fc     RI expression on mast cells. In addition, the low lev-
els of Fc     RI expression found on mast cells from   IgE       /         mice 
were attributed to IL-4 production (  29  ). These fi  ndings now 
indicate that Fc     RI expression on cDCs is also regulated by 
type I IFN. Moreover, expression on cDCs can be regulated 
independent of IgE levels because Fc     RI levels return to 
baseline despite a persistent increase in IgE levels after viral 
infection. Thus, Fc     RI on cDCs may be selectively regulated 
by type I IFN, at least in the mouse. Human cDCs express 
Fc     RI at baseline, but whether these levels are increased by 
viral infection still needs to be determined (  12, 13  ). 
  In that regard, the consequences of IgE production and 
IgE  –  Fc     RI interaction in the setting of viral infection were 
  Figure 7.     Effect of CCL28 blockade on mucous cell metaplasia 
after viral infection. (A) WT mice were inoculated with SeV and treated 
with anti-CCL28 mAb or control IgG2b mAb every other day starting on PI 
day 3. At PI day 21, lung sections were subjected to immunostaining for 
Muc5ac, and representative photomicrographs are shown. Bar, 40     m. 
(B) Quantifi  cation of immunostaining in A. (C) For conditions in A, the 
frequency of lung CD4      T cells was monitored by fl  ow cytometry. Values 
represent the mean       the SEM for four mice per group. *, P       0.05  versus 
control IgG2b treatment.     JEM VOL. 204, October 29, 2007 
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  Mouse generation and handling.     C57BL/6; BALB/c; B6.129S2-
CD4  +tm1Mak  /J (CD4-null); B6.129S2-Cd8a  tm1Mak  /J (CD8-null); and C57BL/6-
Prf1  tm1Sdz  /J (perforin-null) mice were obtained from The Jackson Laboratory. 
TgN(OT-II.2a)Rag1  tm1   (OT-II) mice on a C57BL6 background were obtained 
from the Taconic NIAID Emerging Models Program (Germantown, NY). 
C57BL6 mice defi  cient in CD1d were obtained from A. Bendelac (Univer-
sity of Chicago, Chicago, IL); IFNAR-null mice on a C57BL6 background 
were obtained from J. Sprent (The Scripps Research Institute, La Jolla, CA); 
MyD88-defi  cient mice and WT littermates on a mixed B6/129 back-
ground were a gift from M. Colonna (Washington University, St. Louis, 
MO); Fc     RI     -defi   cient mice on a C57BL6 background were obtained 
from J.-P. Kinet (Harvard Medical School, Boston, MA); and IgE-defi  cient 
mice on a BALB/c background were obtained from H. Oettgen (Harvard 
Medical School, Boston, MA). Mice 6  –  20 wk of age were used for all 
experiments under protocols approved by the University Animal Stud-
ies Committee. 
  Mice were inoculated with SeV (Fushimi strain; American Type Cul-
ture Collection [ATCC]) or UV-inactivated SeV, as previously described, 
using an inoculum of 2       10  5   pfu, and they were monitored daily for weight 
and activity. To track lung cDCs, mice were anesthetized and given 30      l of 
5 mM CFSE intranasally, as previously described (  2, 3, 5, 14  ). For blockade 
of CCL28, mice were given 100      g of anti-CCL28 mAb or control IgG2b 
subcutaneously every other day from PI day 3 to 19. Mucous cell metaplasia 
and   Muc5ac   mRNA in lungs were assessed at PI day 21 as previously de-
scribed (  2, 3, 5  ). 
  Lung cDC isolation.     For cDC isolation, mice were killed, and intracardiac 
injection of PBS was used to fl  ush out the pulmonary and systemic circula-
tions. BAL was performed to remove any cells in the bronchiolar or alveolar 
space. Next, 1 ml of digest media was injected intratracheally. Digest me-
dium consisted of DME supplemented with 5% fetal calf serum, penicillin/
streptokinase, 10 mM Hepes, 250 U/ml collagenase I (Worthington Bio-
chemical), 50 U/ml DNase I (Worthington Biochemical), and 0.01% hyal-
uronidase (Sigma-Aldrich). The lungs were carefully dissected from the 
trachea, main-stem bronchi, draining lymph nodes, and surrounding tissue. 
The lungs were minced and incubated in digest media for 1 h at 37  °  C. Dur-
ing the fi  nal 15 min of incubation time, EDTA was added to a fi  nal concen-
tration of 2 mM. After digestion, the cell mixture was passed through a 
40-     m pore cell strainer to generate single-cell suspensions, and erythrocytes 
were removed by hypotonic lysis. Cell viability was assessed by trypan blue 
exclusion. An analogous procedure was performed for removal of DCs from 
spleen or draining lymph nodes, as well as for isolation of T cells from 
C57BL6 or OT-II splenic tissue. Lung cDCs were identifi  ed (and other cell 
populations, such as macrophages, were excluded) by fl  ow cytometry, as 
previously described (  22  ). 
  Cell purifi  cation and culture.     DCs were purifi  ed from lung cell suspen-
sions using the MACS system (Miltenyi Biotec) for positive immunomag-
netic selection with anti-CD11c microbeads. Using two serial purifi  cations, 
cDC purity was      95%. Cells obtained in this manner had typical cDC mor-
phology (  Fig. 4  ). Purifi  ed cDCs were cultured with or without cross-linking 
antibodies in complete RPMI (Sigma-Aldrich) supplemented with 10% fetal 
calf serum and penicillin/streptokinase (Invitrogen) for 18 h at 37  °  C. For T 
cell proliferation experiments, cDCs were subjected to 200 cGyn before be-
ing loaded with 0.3      M of OVA peptide (OVA  323-339  ). CD4      T cells were 
purifi  ed from OT-II spleens using the Miltenyi-Biotec MACS system for 
positive immunomagnetic selection. T cell purities were      95%. Irradiated 
cDCs (10  4   per condition) were cultured for 4 d with 10  5   OVA-specifi  c 
CD4      T cells with or without cross-linking antibodies. For T cell prolifera-
tion, CD4      T cells were labeled with 5      M CFSE (Invitrogen) before cul-
ture, and cell proliferation was monitored by CFSE dilution, as previously 
described (  42  ). For some experiments, lung cDCs were loaded with 10      g/ml 
mouse anti-OVA IgE (Serotec) for 48 h at 37  °  C, washed, and incubated 
with or without 3      g/ml OVA protein (Sigma-Aldrich) for 18 h at 37  °  C, 
followed by mRNA isolation from cell pellets. Mouse MC/9 mast cells were 
of asthma in the urban environment. In this setting, the in-
creased population density, as well as other factors, may lead 
to increased transmission of respiratory viral infections. If vi-
ral respiratory illnesses drive Fc     RI expression on lung cDCs 
in humans, this process could lead to an increase in lung Th2 
responses in individuals with genetic susceptibility to this 
type of response. This mechanism is consistent with the in-
creased incidence of asthma now being found for children 
living in the inner city (  39  ). 
  In summary, we have defi  ned a new scheme for mucous 
cell metaplasia after viral infection that depends on an IF-
NAR  –  Fc     RI  –  CCL28  –  IL-13 immune axis (Fig. S7, available 
at http://www.jem.org/cgi/content/full/jem.20070360/DC1). 
This mechanism involves cDC expression of Fc     RI and pro-
duction of CCL28 in concert with T cell production of IL-13 
and consequent mucous cell metaplasia. This immune axis may 
be more active after severe infection to help explain why more 
severe respiratory viral infections are associated with an in-
creased risk of asthma. For example, the level of IgE produc-
tion after SeV infection in mice appears to depend on the 
severity of the infection (unpublished data). The scheme also 
implies that exposure to even nonviral IgE and antigen during 
the resolution of the viral response might also lead to increased 
Th2 recruitment to the lung driven by additional Fc     RI cross-
linking and CCL28 production. This mechanism would thereby 
provide for an allergic-type response to nonviral antigens be-
cause Th2 cells that had migrated to the lung could be directed 
against nonviral antigens. In the atopic individual, these Th2 
cells could lead to the development of asthma, or an exacerba-
tion of the disease in patients with established asthma. Each 
of these mechanisms is distinct from previous proposals for 
IgE  –  Fc     RI function in the traditional response to parasitic in-
fection or allergen exposure. Thus, viral antigens and the con-
sequent IFN-dependent antiviral response may also trigger an 
  “  allergic  ”   cascade, leading to disease traits that are characteristic 
of asthma and other chronic airway diseases. 
    MATERIALS AND METHODS   
  Reagents and antibodies.     Anti-CD16/-CD32 antibodies (clone 2.4G2; 
obtained from C. Pham, Washington University, St. Louis, MO) were used 
for fl  ow cytometry, as previously described (  40  ). Anti  –  mouse CCL28 mAb 
or control rat IgG2b was obtained from R  &  D Systems. PE- or allophycocy-
anin-labeled antibodies against mouse CD4, CD8, CD11c, CD23, c-Kit, 
Fc     RI      (clone MAR-1), and IgE, as well as isotype control IgGs (rat and 
Armenian hamster), were obtained from eBioscience or BD PharMingen. 
SeV-specifi  c CD8      T cells were monitored using tetrameric MHC/peptide 
reagents for the immunodominant epitope of SeV nucleoprotein (NP  324-332  ) 
or control OVA peptide (SIINFEKL) complexed with K(b) provided by the 
National Institute of Allergy and Infectious Diseases (NIAID) Tetramer 
Core Facility (  41  ). Purifi  ed anti-Fc     RI      mAb (clone MAR-1; eBioscience) 
was used for immunoprecipitation, and anti-Fc     RI      mAb (clone JRK) ob-
tained from J. Rivera (National Institutes of Health, Bethesda, MD) or rabbit 
anti-Fc     RI      Ab (Millipore) was used for detection of the immune complex 
in Western blotting. For cross-linking experiments, functional grade Arme-
nian hamster anti  –  murine Fc     RI      or functional grade Armenian hamster 
IgG isotype control antibodies were obtained from eBioscience. A secondary 
goat anti  –  Armenian hamster IgG antibody purchased from Jackson Immuno-
Research Laboratories was also used. 2768 Fc    RI     AND VIRUS-INDUCED MUCOUS CELL METAPLASIA | Grayson et al.
  Statistical analyses.     Unless otherwise stated, all data are presented as the 
mean       the SEM. Student  ’  s   t   test was used to assess statistical signifi  cance 
between means. For nonnormally distributed data, comparison of medians 
was made using a Mann-Whitney   U   test. For comparison of ratios, Wilcoxin 
Signed Rank was used. In all cases, signifi  cance was set at P       0.05. 
  Online supplemental material.       FceRIa       /         and WT mice respond simi-
larly to SeV infection, as shown in Fig. S1. Surface marker expression on 
lung cDCs from   FceRIa       /         and WT mice are similar, as shown in Fig. S2. 
Fig. S3 shows that IFNAR expression on lung cDCs is not necessary for 
Fc     RI      expression on lung cDCs. Fig. S4 shows the eff  ect of cDC Fc     RI 
activation on chemotaxis of CD4      T cells. The ability of WT, but not 
  FceRIa       /        , cDC to restore postviral-induced mucous cell metaplasia in 
  FceRIa     /         mice is demonstrated in Fig. S5. Fig. S6 shows that postviral 
  Muc5ac   mRNA induction is inhibited with CCL28 blockade. As shown 
in Fig. S7, our data support a scheme whereby an IFN  –  Fc     RI  –  CCL28  –
  IL-13 signaling pathway regulates mucous cell metaplasia after viral in-
fection. The online version of this article is available at http://www.jem
.org/cgi/content/full/jem.20070360/DC1. 
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obtained from the ATCC and were maintained in ATCC complete growth 
medium (DME with 2 mM   l-  glutamine, 0.05 mM 2-ME, 4.5 g/liter glu-
cose, and 1.5 g/liter sodium bicarbonate) supplemented with 10% fetal calf 
serum and 10% Rat T-Stim (BD Biosciences) (  43  ). 
  Immunoprecipitation and Western blot analysis.     Immunoprecipita-
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iodoacetamide, 10      g/ml leupeptin, 10      g/ml pepstatin, and 100      g/ml 
soybean trypsin inhibitor). Aliquots of samples containing 500      g protein 
were immunoprecipitated using 20      l of protein A  –  Sepharose beads conju-
gated to 25      g of rabbit secondary antibody. Immune complexes were sepa-
rated by nonreducing PAGE, and then detected by Western blotting onto an 
Immobilon-P PVDF membrane (Millipore), probed with anti-Fc     RI      or 
-Fc     RI      antibodies, and imaged with chemiluminescence (SuperSignal West 
Pico kit; Pierce Chemical Co.). 
  Adoptive transfer protocol.     Lung cDCs were purifi  ed from C57BL6, 
  IFNAR       /        , or   FceRIa       /         mice and delivered intranasally to anesthetized 
recipient C57BL6 or   FceRIa       /       mice (2.5       10  5   cells in 30      l of PBS given 
1 d before SeV inoculation). In some experiments, cDCs were loaded with 
either CFSE or TAMRA-SE (Invitrogen), as previously described (  40  ). 
No diff  erence in transfer effi   ciency (engraftment) was seen with either dye 
(unpublished data). 
  Chemotaxis assay.     Chemotaxis was monitored with a modifi  ed Boyden 
chamber, as previously described (  46  ). For these experiments, CD4      T cells 
were purifi  ed from naive C57BL6 spleen, and 2.5       10  4   cells in 50      l were 
loaded in the upper chamber, which was separated from the lower chamber 
by a 5-     m membrane (Neuro Probe, Inc.). A 25-     l aliquot of a 1:3 dilution 
of supernatant from lung cDC cultures was placed in the lower chamber. In 
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anti  –  mouse CCL28 antibody (100      g/ml) was added to the lower chamber. 
After a 3-h incubation at 37  °  C, the number of cells that had transmigrated 
into the lower chamber was determined by fl  ow cytometry, as previously 
described (  46  ). Results are calculated as a migration index that represents the 
ratio of cells migrating in each condition compared with the number migrat-
ing to CCL21 control (1      g/ml; R   &   D Systems). 
  Real-time PCR assay.     mRNA was isolated with the RNeasy kit (Qiagen) 
or Trizol (Sigma-Aldrich) and used to generate cDNA with Applied Biosys-
tems cDNA archive kit as per the manufacturer  ’  s instructions. Quantitative 
real-time PCR assays were performed using an Applied Biosystems 7500 
Fast real-time PCR system and TaqMan fast master mix. In addition to 
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pression arrays (mouse primer and probe sets) for PCR were obtained from 
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Mm01276725_g1),   CCL28   (assay ID Mm00445039_m1),   GATA-3   (assay 
ID Mm00484683_m1),   Fc     RI       (assay ID Mm00438867_m1), and   Fc     RI       
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SeV-coated plates from Charles River Laboratories were substituted for cap-
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determined using a commercially available ELISA kit (Invitrogen). JEM VOL. 204, October 29, 2007 
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